Pharmacotherapy Principles and Practice. (Record no. 29787)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03502nam a22003737a 4500 |
| 001 - CONTROL NUMBER | |
| control field | 20241111094747.0 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20241111095533.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 241111b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 978-0-07-180423-3 |
| International Standard Book Number | 978-0-07-178046-9 |
| International Standard Book Number | 0-07-178046-7 |
| International Standard Book Number | 0-07-180423-4 |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | ddc |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | English |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Fuller form of name | Marie A. Chisholm-Burns |
| 222 ## - KEY TITLE | |
| Key title | Pharmacotherapy Principles and Practice |
| Qualifying information | ACE inhibitors acid acidosis activity acute administration adverse effects agents alteplase angina anticoagulant artery assess associated asthma bivalirudin bleeding blockers blood pressure BP calcium cardiac cardiovascular cause cells chronic CKD clinical clopidogrel contraindications COPD coronary corticosteroids creatinine dabigatran decrease diabetes diagnosis diarrhea digoxin disease diuretics dose drug therapy dysfunction dyspnea Engl enzyme Evaluation exacerbations fluid fondaparinux function goal greater guidelines heart failure heparin hepatitis HF Hg hyperkalemia hypertension hypotension increased infection inhaled initial INR ischemic kidney less liver loop diuretics mcg medications mEq/L metabolic mg mg/dL mmol/L monitoring mortality myocardial infarction nausea and vomiting Nonpharmacologic normal NSAIDs NSTE oral outcomes oxygen pain palliative care pancreatitis Patient Encounter PCI pediatric pharmacologic Pharmacotherapy Pharmacy PharmD platelet potassium potential prevention pulmonary receptor recommended reduce regimen renal result risk factors serum sodium ẞ-blockers statin stroke symptoms syndrome Table therapeutic treatment trial twice daily UFH ulcer venous ventricular VTE warfarin |
| 240 ## - UNIFORM TITLE | |
| Uniform title | Pharmacotherapy Principles and Practice. |
| 245 ## - TITLE STATEMENT | |
| Title | Pharmacotherapy Principles and Practice. |
| 246 ## - VARYING FORM OF TITLE | |
| Title proper/short title | Pharmacotherapy Principles and Practice. |
| 247 ## - FORMER TITLE | |
| Title | Pharmacotherapy Principles and Practice. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 3rd. Edition |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Philadelphia | |
| Name of publisher, distributor, etc. | McGraw-Hill Education, LLC | |
| Date of publication, distribution, etc. | 2013 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1669 Pages |
| Extent | Includes Index |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Learn the essential principles of pharmacotherapy and how they apply to today’s healthcare<br/><br/>Pharmacotherapy Principles & Practice, Third Edition uses a solid evidence-based approach to teach you how to design, implement, monitor, and evaluate medication therapy. This trusted text provides everything you need to gain an in-depth understanding of the principles essential to the optimal pharmacotherapy of disease. In order to be as clinically relevant as possible, the disease states and treatments discussed focus on disorders most often seen in clinical practice. Chapters were written or reviewed by pharmacists, nurse practitioners, physician assistants, and physicians who are authorities in their fields.<br/><br/>The book opens with an introductory chapter followed by chapters on pediatrics, geriatrics, and palliative care. The remainder of the text consists of ninety-eight disease-based chapters that review etiology, epidemiology, pathophysiology, and clinical presentation, followed by therapeutic recommendations for drug selection, dosing, and patient monitoring. |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| General subdivision | Medical / Pharmacology, Medical / Pharmacy, Chemotherapy -- Textbooks, Drug Therapy, Medical / Chemotherapy, Chemotherapy |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Fuller form of name | Barbara G. Wells |
| Fuller form of name | Terry L. Schwinghammer |
| Fuller form of name | Joseph T. DiPiro |
| Fuller form of name | Jill M. Kolesar |
| Fuller form of name | Patrick M. Malone |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | ddc |
| Koha item type | E-BOOKS |
| Suppress in OPAC | |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total checkouts | Barcode | Date last seen | Copy number | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 11/11/2024 | 20241111094747.0 | 11/11/2024 | 20241111094747.0 | 11/11/2024 | E-BOOKS |